The HER2-Positive Breast Cancer Market is estimated to be valued at USD 10.96 bn in 2025 and is expected to reach USD 12.94 bn by 2032, growing at a compound annual growth rate (CAGR) of 2.4% from 2025 to 2032. https://timessquarereporter.com/news/her2-positive-breast-cancer-market-to-grow-on-precision-therapy-advances